Why a Boston-Bred Biotech Founder Chose California for His Startup
Felix Wong's biotech startup thrives in California's culture despite his Massachusetts roots and impressive academic pedigree.
August 07, 2026
Technology
Latest technology news and innovations
Replimune's Tumultuous Journey Ends with FDA Approval of Melanoma Treatment
Replimune's advanced melanoma drug, RP1, receives FDA approval after a challenging path, bringing hope to patients with a hefty price tag.
August 06, 2026
Medicare's Policy Shift Delays Price Negotiations for Key AbbVie Drug
A recent Medicare policy change has postponed the price negotiations for a major AbbVie drug, potentially impacting taxpayers significantly.
August 06, 2026
New Insights into Tau's Role in Alzheimer's Open Doors for Potential Treatments
A recent study reveals tau protein’s unexpected influence on cellular function, suggesting novel strategies for Alzheimer’s treatment.
August 06, 2026
FDA Grants Approval for New Drug and Vaccine, Impacting Biotech Landscape
The FDA has recently approved a new therapeutic drug and a vaccine, shaping the future direction of biotechnology and addressing pressing health needs.
August 06, 2026
FDA Approval of Takeda's Orzeyful Marks a Shift in Narcolepsy Treatment
The FDA has approved Takeda's Orzeyful, a new orexin receptor agonist that promises to improve daytime alertness for narcolepsy patients.
August 05, 2026
Federal Regulators Engage with Tech Giants to Shape Clinical AI Policies
Federal health officials convene with major tech firms to discuss the future of clinical AI, aiming for safe implementation and regulatory clarity.
August 05, 2026
Fecal Microbiome Transplants Show Promise for Treating Peanut Allergies
A clinical trial indicates potential for fecal microbiome transplants to improve peanut allergy tolerance, exciting experts in the field.
August 05, 2026
Scrutiny Grows on Chinese Gene-Editing Trials Following Child's Death
A child’s death in a CRISPR gene-editing trial by HuidaGene raises serious concerns about safety and regulatory oversight in China’s biotech sector.
August 05, 2026
Moderna Initiates First Clinical Trial for Ebola mRNA Vaccine
Moderna has launched a clinical trial for its mRNA-based Ebola vaccine, marking a significant step in combating this viral disease.
August 05, 2026
Reassessing AI Potential: Insights from Schrödinger’s CEO Ramy Farid
Ramy Farid of Schrödinger reflects on the evolving role of AI in biotech, envisioning clearer perceptions in the industry within five years.
August 05, 2026
Medicare Pilot and Pharma Developments: Key Updates on Orphan Drugs and Merger Talks
A recent Medicare pilot proposal risks reducing savings for retail drugs. Meanwhile, merger talks between AstraZeneca and Bristol Myers Squibb have been denied.
August 05, 2026
Medicaid's New Toolkit for Autism Therapy: Shifting Oversight in Behavior Analysis
A new Medicaid toolkit emphasizes stricter oversight and measurable outcomes for autism therapies, raising concerns around ABA services and telehealth.
August 05, 2026
Impact of Excluding Rare Disease Treatments from Medicare Drug Pricing Pilots
Excluding rare disease therapies from Medicare's drug pricing pilots could significantly reduce overall savings, according to recent research.
August 05, 2026
Rethinking Prostate Cancer Diagnosis: The Role of MRI vs. Traditional Methods
Despite high diagnosis rates, many U.S. men miss out on MRI screenings for prostate cancer, which could lead to better outcomes.
August 05, 2026
Novo Nordisk's Heart Drug Fails to Reduce Major Cardiac Events in Key Trial
Novo Nordisk's ziltivekimab, aimed at targeting inflammation, showed no reduction in cardiovascular events despite lowering inflammation markers.
July 31, 2026
The American Diabetes Association's Shift from Courage to Controversy
The American Diabetes Association, once praised for its bravery, now faces criticism for its handling of dissent within the medical community.
July 31, 2026
Navigating the Challenges of Limb Girdle Muscular Dystrophy Treatment Development
As advancements accelerate in rare disease therapies, LGMD patients face urgency, with time impacting their muscle function and access to new treatments.
July 31, 2026
Research and Challenges in San Diego's Fight Against Syphilis Spread
In San Diego, a surge in syphilis cases highlights the challenges researchers face amid a drug shortage and complex patient interactions.
July 31, 2026
Capricor's FDA Hearing: Scrutiny Amid Leadership Changes and Industry Challenges
Capricor Therapeutics faces skepticism over its Duchenne MD therapy data, while the biotech sector grapples with leadership turmoil and FDA scrutiny.
July 30, 2026